TNS, a Subsidiary of DENTIS, Raises Additional KRW 4.75 Billion, Totaling KRW 15.75 Billion
TNS, a subsidiary of the Korean digital dentistry company DENTIS, has secured an additional investment of KRW 4.75 billion, reaching a total accumulated investment of KRW 15.75 billion in just over six months.
TNS has carried out four rounds of investment since October last year. This latest round of KRW 4.75 billion has successfully pushed the total investment beyond the initial target of KRW 15 billion.
DENTIS stated, “During TNS’s investment process, we confirmed the positive evaluation of the growth potential of the clear aligner market and the competitiveness of our clear aligner brand, SERAFIN. Particularly, the recognition of our product quality and the technological capability of our digital clear aligner treatment platform has positioned us to prepare for a leap into becoming a global brand. This is based on strong confidence in SERAFIN’s technological competitiveness in the rapidly growing global clear aligner market.”
TNS plans to use the investment funds to focus on research and development aimed at enhancing its digital clear aligner system. The strategy also includes expanding the manufacturing infrastructure to meet the increasing domestic demand and proactively enhancing production capabilities in anticipation of entering international markets.
SERAFIN was developed as a comprehensive digital clear aligner platform service and officially launched in 2021. Based on clinical validation by a group of orthodontic experts, it enables diagnosis, setup (design), and manufacturing using a 3D printer, all through a digital platform. The entire process of diagnosis, setup, and manufacturing for clear aligner treatment is conducted on this single platform.
In March of last year, SERAFIN became the first clear aligner in South Korea to receive European CE MDR certification. Following this, in October, DENTIS completed the first domestic patent registration for MESHEET, a new material for manufacturing clear aligners, and is preparing for its launch within the first quarter. The company plans to enhance its cost competitiveness with this new material and increase its profitability by entering the global market.
[Korean bioHealth Startups News]
- SEOUL BIOHUB Global Center Opens, Aiming to Boost Global BioTech Competitiveness
- Delight Room Invests in Soundable Health for Advanced Sound Analysis in Healthcare
- Apollon Secures 2.3 Billion KRW in Funding for Innovative Needle-Free CGM Technology
- Korean Space Medicine Startup SpaceLiintech Lands 4 Billion KRW Series A Funding
- ArtBlood Secures KRW 6.5 Billion in Series A for Synthetic Blood Production
- GLOUD Raises 3B KRW in Pre-Series A for Global Dental Digital Transformation Expansion
- Protium Science and HK innoN Forge Strategic Investment & Partnership
- LabInCube Raises KRW 5.1B in Series A for MOF Material Development
- Prevenotics Secures Investment for AI-Based Cancer Prevention from 500 Global
- Syntekabio Secures KRW 10B for AI Drug Development from Korea Investment Partners
